Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)

Award Number: U01AI069923
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/15/2006
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) - The Caribbean, Central and South America network for HIV epidemiology (CCASAnet) is an established and productive network within the International epidemiology Databases to Evaluate AIDS (leDEA) program. CCASAnet was created in 2006 during the first leDEA funding cycle and has brought together clinical, statistical, epidemiologic, and informatics resources from HIV clinical care and research sites in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, Peru, and the United States. The CCASAnet Data Coordinating Center at Vanderbilt University Medical Center (VDCC) manages the CCASAnet consortium and harmonizes and analyzes the complex databases generated by participating sites while developing new biostatistics and informatics methods that support global observational research. The VDCC also provides mentoring and education to enhance clinical research and data management capabilities, promote junior researchers, and catalyze ongoing growth of scientific leadership in HIV research at Vanderbilt and at CCASAnet sites. Over the next cycle, CCASAnet will assess the HIV continuum of care across the Americas, those lost to follow-up , and pregnant women. CCASAnet will also focus on prediction and prevention of non-communicable diseases as well as treatment outcomes in tuberculosis patients with and without HIV. We will also characterize substance use, mental health, and non-communicable disease clinical outcomes in adolescents and older persons through prospective studies nested in the CCASAnet retrospective clinical cohort. These investigations provide real-world epidemiologic lessons that improve the clinical care of people with HIV in the US and around the world. We will continue to expand our productive collaborations with other IeDEA regions, and provide leadership in site assessment, data harmonization, and data sharing initiatives. Through these activities, CCASAnet elevates HIV research and research education across the Americas and accelerates the methodology and data sciences that underpin US and international research findings.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $2,785,716 )
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	019	22	7/18/2026	SUPPLEMENT FOR EXPANSION	$123,962
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	016	22	7/15/2026	SUPPLEMENT FOR EXPANSION	$84,715
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	021	22	7/20/2026	SUPPLEMENT FOR EXPANSION	$255,568
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	020	22	7/19/2026	SUPPLEMENT FOR EXPANSION	$93,006
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	023	22	7/22/2026	SUPPLEMENT FOR EXPANSION	$220,447
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	017	22	7/16/2026	SUPPLEMENT FOR EXPANSION	$60,653
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	015	22	7/14/2026	SUPPLEMENT FOR EXPANSION	$224,528
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	014	22	7/13/2026	SUPPLEMENT FOR EXPANSION	$117,131
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	022	22	7/21/2026	SUPPLEMENT FOR EXPANSION	$86,779
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	018	22	7/17/2026	SUPPLEMENT FOR EXPANSION	$86,884
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	013	22	7/1/2026	EXTENSION WITH OR WITHOUT FUNDS	$1,432,043
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	010	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	012	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	009	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	007	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	005	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	004	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	003	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	008	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	006	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	21	12/10/2025	NON-COMPETING CONTINUATION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	011	21	6/30/2026	SUPPLEMENT FOR EXPANSION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	002	21	6/29/2026	NON-COMPETING CONTINUATION	$0
2026	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	21	3/6/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,785,716

Issue Date FY: 2025 ( Subtotal = $2,771,216 )
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	002	21	9/1/2025	SUPPLEMENT FOR EXPANSION	$201,213
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	21	8/29/2025	SUPPLEMENT FOR EXPANSION	$108,600
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	21	8/21/2025	NON-COMPETING CONTINUATION	$1,569,619
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	004	21	9/3/2025	SUPPLEMENT FOR EXPANSION	$48,219
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	009	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$81,526
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	010	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$220,447
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	005	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$88,166
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	003	21	9/2/2025	SUPPLEMENT FOR EXPANSION	$60,289
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	006	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$103,627
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	008	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$204,915
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	007	21	9/4/2025	SUPPLEMENT FOR EXPANSION	$84,595
														Subtotal = $2,771,216

Issue Date FY: 2024 ( Subtotal = $3,088,719 )
2024	2024	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	20	5/24/2024	NON-COMPETING CONTINUATION	$3,088,719
														Subtotal = $3,088,719

Issue Date FY: 2023 ( Subtotal = $3,159,329 )
2023	2023	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	19	4/13/2023	NON-COMPETING CONTINUATION	$3,159,329
														Subtotal = $3,159,329

Issue Date FY: 2022 ( Subtotal = $3,135,682 )
2022	2022	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	002	18	5/26/2022	NON-COMPETING CONTINUATION	$3,135,682
2022	2022	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	004	18	8/24/2022	NON-COMPETING CONTINUATION	$0
2022	2021	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	17	4/1/2022	COMPETING CONTINUATION	$1,384,669
2022	2021	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	003	17	8/24/2022	COMPETING CONTINUATION	$0
2022	2020	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	16	4/1/2022	NON-COMPETING CONTINUATION	-$1,384,669
														Subtotal = $3,135,682

Issue Date FY: 2021 ( Subtotal = $3,250,000 )
2021	2021	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	17	6/1/2021	COMPETING CONTINUATION	$3,250,000
2021	2020	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	16	2/17/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,250,000

Grand Total All Awards = $41,637,837

Page 1 of 3 (117 items)12 3

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)

Award Number: U01AI069923

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/15/2006

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer